Product Information
LIDOCAINE 5% PATCH is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.9204 per EA under NDC 00378905593. Its NADAC has been published 553 times since Sep 30, 2015.
FDA first approved this application on Aug 7, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
140 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378905593
Classification
Generic
Dosage Form
PATCH
Route
CUTANEOUS
Effective Date
4/22/2026
Active Ingredients
LIDOCAINEApproval Type
Generic (ANDA)
FDA Application
ANDA202346FDA Approved
8/7/2015
TE Code
AB
On Market Since
8/7/2015
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE 5% PATCH has been published 553 times since Sep 30, 2015, and over the history we have for it it has declined 66.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9204 per EA |
|---|---|
| All-time high | $5.7859 (Oct 14, 2015) |
| All-time low | $1.7004 (Apr 17, 2024) |
| 52-week high | $2.1180 |
| 52-week low | $1.9204 |
| Median price | $2.2232 |
| Average price | $2.5200 |
| Largest weekly change | +15.1% (May 22, 2019) |
| Weeks tracked | 553 |
| Tracking since | Sep 30, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
-2.7%
1Y
-6.1%
3Y
+0.3%
5Y
-8.8%
All
-66.8%
Last surveyed Apr 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lidocaine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
lidocaine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE 5% PATCH?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE 5% PATCH, manufactured by Mylan Pharmaceuticals Inc., is $1.9204 per EA (NDC 00378905593), effective Apr 29, 2026.
How has the price of LIDOCAINE 5% PATCH changed over time?
Over the history we have for it, the NADAC for LIDOCAINE 5% PATCH has declined 66.8%. It has been tracked across 553 weekly CMS publications since Sep 30, 2015.
What are the highest and lowest recorded NADAC prices for LIDOCAINE 5% PATCH?
Since Sep 30, 2015, the NADAC for LIDOCAINE 5% PATCH has ranged from a low of $1.7004 (Apr 17, 2024) to a high of $5.7859 (Oct 14, 2015), with a median of $2.2232 per EA.
Are there cheaper alternatives to LIDOCAINE 5% PATCH?
No other NADAC-published product currently shares the active ingredient and strength of LIDOCAINE 5% PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LIDOCAINE 5% PATCH?
LIDOCAINE 5% PATCH (NDC 00378905593) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.